Diagnosis Code C92.02
Information for Medical Professionals
The diagnosis code C92.02 is grouped in the following Diagnostic Related Group(s) (MS-DRG v33.0)
- LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITH MCC 820
- LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITH CC 821
- LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITHOUT CC/MCC 822
Convert to ICD-9 General Equivalence Map
The ICD-10 and ICD-9 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.
- 205.02 - Act myel leuk in relapse (approximate) Approximate Flag
The approximate flag is on, indicating that the relationship between the code in the source system and the code in the target system is an approximate equivalent.
Information for Patients
Also called: AML, ANLL, Acute myelogenous leukemia
Leukemia is cancer of the white blood cells. White blood cells help your body fight infection. Your blood cells form in your bone marrow. In leukemia, however, the bone marrow produces abnormal white blood cells. These cells crowd out the healthy blood cells, making it hard for blood to do its work. In acute myeloid leukemia (AML), there are too many of a specific type of white blood cell called a myeloblast.
AML is the most common type of acute leukemia in adults. This type of cancer usually gets worse quickly if it is not treated. Possible risk factors include smoking, previous chemotherapy treatment, and exposure to radiation.
Symptoms of AML include:
- Shortness of breath
- Easy bruising or bleeding
- Bleeding under the skin
- Weakness or feeling tired
- Weight loss or loss of appetite
Tests that examine the blood and bone marrow diagnose AML. Treatments include chemotherapy, other drugs, radiation therapy, stem cell transplants, and targeted therapy. Targeted therapy uses substances that attack cancer cells without harming normal cells. Once the leukemia is in remission, you need additional treatment to make sure that it does not come back.
NIH: National Cancer Institute
- Acute myelogenous leukemia (AML) -- children
- Acute myeloid leukemia
- After chemotherapy - discharge
- Bone marrow transplant
- Bone marrow transplant - discharge
- Understanding Chemotherapy - NIH - Easy-to-Read (National Cancer Institute)
- What to Know about External Beam Radiation Therapy - NIH - Easy-to-Read (National Cancer Institute)